Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma

INTRODUCTION: Clinical application of antiangiogenic therapy lacks direct visualization of therapy efficacy and vascular resistance. We aimed to establish molecular imaging during treatment with sunitinib using the fibronectin extradomain A specific small immunoprotein(SIP)-F8 in glioma. METHODS: Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Acker, Güliz, Piper, Sophie Käthe, Datwyler, Anna Lena, Broggini, Thomas, Kremenetskaia, Irina, Nieminen-Kelhä, Melina, Lips, Janet, Harms, Ulrike, Mueller, Susanne, Lättig-Tünnemann, Gilla, Trachsel, Eveline, Palumbo, Alessandro, Neri, Dario, Klohs, Jan, Endres, Matthias, Vajkoczy, Peter, Harms, Christoph, Czabanka, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021244/
https://www.ncbi.nlm.nih.gov/pubmed/29963235
http://dx.doi.org/10.18632/oncotarget.25570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021244/
https://www.ncbi.nlm.nih.gov/pubmed/29963235
http://dx.doi.org/10.18632/oncotarget.25570

Ejemplares similares